Agios Pharmaceuticals briefly spikes after positive study results

Shares of Agios Pharmaceuticals briefly popped more than 8 percent after reporting encouraging data on its lead drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.